|
|
|
|
|
| |
- The Canada-European Union Comprehensive Economic & Trade Agreement: An Economic Impact Assessment of Proposed Pharmaceutical Intellectual Property Provisions
With Aidan Hollis; February 7, 2011
(download article in PDF format)
- Economic Policy, Obesity and Health: A Scoping Review
With
Faulkner G, Nguyen VH, Ferrence R, Mendelson R, Donnelly P, Arbour-Nicitopoulos K.;
July 2010
(download article in PDF format)
- An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada
With Marie Rocchi,
Harold Segal;
Research Assistants:
Chakshu Gupta,
MS Shim; November 21, 2008
(download article in PDF format)
- Effects of ‘authorized generics’ on Canadian drug prices. SEDAP Research Paper No. 201. Also appears in: Marcel Boyer, Michael Trebilcock and David Vaver, eds. Competition Policy and Intellectual Property. Toronto: Irwin Law Inc., 2009.
http://socserv.mcmaster.ca/sedap/p/sedap201.pdf
- The Impact
of Reference Pricing of Cardiovascular Drugs on Health Care Costs
and Health Outcomes. Vol I: Summary.
With L Dolovich, A Holbrook, A Levy, B O'Brien;
Revised October 4, 2001.
(download article in PDF format)
- The Impact
of Reference Pricing of Cardiovascular Drugs on Health Care Costs
and Health Outcomes.Vol II: Technical Report.
With L Dolovich, A Holbrook, A Levy, B O'Brien;
Revised October 4, 2001.
(download article in PDF format)
- The Impact
of Reference Pricing of Cardiovascular Drugs on Health Care Costs
and Health Outcomes.Vol III: ACECCB Literature Review.
With L Dolovich, A Holbrook, A Levy, B O'Brien;
Revised October 4, 2001.
(download article in PDF format)
|
|
|
